| This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. (Transferor Company) with the Company (Ipca Laboratories Ltd.) (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. | | Powered by Capital Market - Live News |
|